Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report
Jordi Monés,1,2 Marc Biarnés,1 Josep Badal11Institut de la Màcula i de la Retina, Barcelona, Spain; 2Barcelona Macula Foundation, Barcelona, SpainIntroduction: The management of large pigment epithelial detachments (PEDs) associated with retinal angiomatous prolifera...
Guardado en:
Autores principales: | Monés J, Biarnés M, Badal J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5ef649141df4f0d9c45c5e8ac196740 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retinal pigment epithelium tear after intravitreal aflibercept injection
por: Saito M, et al.
Publicado: (2013) -
Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
por: Arias L, et al.
Publicado: (2016) -
Evaluation of retinal pigment epithelium changes in serous pigment epithelial detachment in age-related macular degeneration
por: Masahiro Miura, et al.
Publicado: (2021) -
Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment
por: Inoda S, et al.
Publicado: (2019) -
Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Roberto Gallego-Pinazo, et al.
Publicado: (2011)